Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Koren
Michael Koren
Amgen
Evolocumab
Medicine
Internal medicine
Cardiology
Diabetes mellitus
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
REDUCTION IN LIPOPROTEIN (A) WITH EVOLOCUMAB: ELUCIDATION OF THE ROLE OF THE LDL RECEPTOR FROM CLINICAL TRIALS AND IN-VITRO MODELS
2016
Journal of the American College of Cardiology
Frederick Raal
Robert P. Giugliano
Marc S. Sabatine
Michael Koren
Dirk Blom
Nabil G. Seidah
Narimon Honarpour
Armando Lira Pineda
Allen Xue
Simon Jackson
Mei Di
Matthew Peach
Ransi Somaratne
Scott M. Wasserman
Rob Scott
Evan A. Stein
Show All
Source
Cite
Save
Citations (1)
TWO YEAR ANALYSIS OF THE SAFETY AND TOLERABILITY OF EVOLOCUMAB: THE OSLER-1 STUDY
2015
Journal of the American College of Cardiology
Michael Koren
Robert P. Giugliano
Frederick Raal
David Sullivan
Michael Bolognese
Gisle Langslet
Fernando Civeira
Andrew Lowy
Ransi Somaratne
Thomas Liu
Scott M. Wasserman
Rob Scott
Marc S. Sabatine
Show All
Source
Cite
Save
Citations (1)
CLINICAL EQUIVALENCE OF EVOLOCUMAB 140 MG EVERY TWO WEEKS AND 420 MG MONTHLY DOSING REGIMENS: A POOLED ANALYSIS OF 3146 PATIENTS IN PHASE 3 STUDIES
2015
Journal of the American College of Cardiology
Evan A. Stein
Michael Koren
Narimon Honarpour
Christopher Kurtz
Jingyuan Yang
Scott M. Wasserman
Frederick Raal
Show All
Source
Cite
Save
Citations (6)
LDL CHOLESTEROL REDUCTION IN ELDERLY PATIENTS WITH THE PCSK9 MONOCLONAL ANTIBODY EVOLOCUMAB (AMG 145): A POOLED ANALYSIS OF 1779 PATIENTS IN PHASE 2, 3 AND OPEN LABEL EXTENSION STUDIES
2015
Journal of the American College of Cardiology
Michael Koren
Robert Rosenson
Bobby Khan
Narimon Honarpour
Mary Jane Elliott
Ransi Somaratne
Scott M. Wasserman
Erik Stroes
Show All
Source
Cite
Save
Citations (7)
1